Fri. 09/28
Poster session 2 (P30-P39) / 1.15 - 2.00 pm
Poster Session 2
Chairman 1: R. Banares, Madrid, Spain / Chairman 2: A. Kribben, Essen, Germany

01.15 - 02.00 pm  P30 Neogenesis of liver struactural units after cotransplantation of liver and bone marrow cells as a basis for prolonged recovery of damaged liver
M. Shagidulin, Moscow, Russia
   P31 Impact of Albumin Dialysis on  Albumin Binding Function    - an in vivo study
M. Kretschmann, Rostock, Germany
   P32 Efficient differentiation of human induced pluripotent stem cells to definitive endoderm on functionalized nanofibers
M. Kazemi-Ashtiani, Tehran, Iran
   P33 Prospective validation of cross organ serum protein biomarkers – Initial results with CXCL9 and CD44 for diagnosis of acute liver rejection
K.A. Prabowo, Berlin, Germany
   P34 Association of OASL gene with chronic HCV therapy response to pegylated interferon-α and ribavirin
S. Kiprijanovska, Skopje, Macedonia
   P35 Characterization of liver cell culture in micro-fluidic biochips by a real time imaging analysis
M. Naudot, Compiégne, France
   P36 Experience of application of Prometeus liver support therapy on patients with hepatorenal syndrome
Y. Santotski, Minsk, Belarus
   P37 Comparison of Extracorporeal Liver Assist System (ELAD®) vs. Standard Care in Treating Chinese Patients with Acute-on-Chronic Liver Failure
Z. Duan, Beijing, China
   P38 Hepatocyte toxicity of industrial stabilizers in commercial human serum albumin
M. Stiffel, Rostock, Germany
   P39 Impact of Albumin Dialysis on Albumin Binding Function  - an in vitro study
L. Borufka, Rostock, Germany